186 related articles for article (PubMed ID: 25853654)
21. Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection.
Garg N; Tarleton RL
Infect Immun; 2002 Oct; 70(10):5547-55. PubMed ID: 12228281
[TBL] [Abstract][Full Text] [Related]
22. Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.
Bhatia V; Sinha M; Luxon B; Garg N
Infect Immun; 2004 Nov; 72(11):6245-54. PubMed ID: 15501750
[TBL] [Abstract][Full Text] [Related]
23. Immunotherapy of Trypanosoma cruzi infection with DNA vaccines in mice.
Dumonteil E; Escobedo-Ortegon J; Reyes-Rodriguez N; Arjona-Torres A; Ramirez-Sierra MJ
Infect Immun; 2004 Jan; 72(1):46-53. PubMed ID: 14688079
[TBL] [Abstract][Full Text] [Related]
24. DNA sequences encoding CD4+ and CD8+ T-cell epitopes are important for efficient protective immunity induced by DNA vaccination with a Trypanosoma cruzi gene.
Fujimura AE; Kinoshita SS; Pereira-Chioccola VL; Rodrigues MM
Infect Immun; 2001 Sep; 69(9):5477-86. PubMed ID: 11500420
[TBL] [Abstract][Full Text] [Related]
25. Oral multicomponent DNA vaccine delivered by attenuated Salmonella elicited immunoprotection against American trypanosomiasis.
Cazorla SI; Matos MN; Cerny N; Ramirez C; Alberti AS; Bivona AE; Morales C; Guzmán CA; Malchiodi EL
J Infect Dis; 2015 Mar; 211(5):698-707. PubMed ID: 25160983
[TBL] [Abstract][Full Text] [Related]
26. Effect of the plasmid-DNA vaccination on macroscopic and microscopic damage caused by the experimental chronic Trypanosoma cruzi infection in the canine model.
Rodríguez-Morales O; Carrillo-Sánchez SC; García-Mendoza H; Aranda-Fraustro A; Ballinas-Verdugo MA; Alejandre-Aguilar R; Rosales-Encina JL; Vallejo M; Arce-Fonseca M
Biomed Res Int; 2013; 2013():826570. PubMed ID: 24163822
[TBL] [Abstract][Full Text] [Related]
27. Vaccination with Trypanosoma rangeli modulates the profiles of immunoglobulins and IL-6 at local and systemic levels in the early phase of Trypanosoma cruzi experimental infection.
Marini V; Moretti E; Bermejo D; Basso B
Mem Inst Oswaldo Cruz; 2011 Feb; 106(1):32-7. PubMed ID: 21340352
[TBL] [Abstract][Full Text] [Related]
28. TcVac3 induced control of Trypanosoma cruzi infection and chronic myocarditis in mice.
Gupta S; Garg NJ
PLoS One; 2013; 8(3):e59434. PubMed ID: 23555672
[TBL] [Abstract][Full Text] [Related]
29. Therapeutic Efficacy of a Subunit Vaccine in Controlling Chronic Trypanosoma cruzi Infection and Chagas Disease Is Enhanced by Glutathione Peroxidase Over-Expression.
Gupta S; Smith C; Auclair S; Delgadillo Ade J; Garg NJ
PLoS One; 2015; 10(6):e0130562. PubMed ID: 26075398
[TBL] [Abstract][Full Text] [Related]
30. Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.
Cazorla SI; Becker PD; Frank FM; Ebensen T; Sartori MJ; Corral RS; Malchiodi EL; Guzmán CA
Infect Immun; 2008 Jan; 76(1):324-33. PubMed ID: 17967857
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant effect of the Propionibacterium acnes and its purified soluble polysaccharide on the immunization with plasmidial DNA containing a Trypanosoma cruzi gene.
Mussalem JS; Vasconcelos JR; Squaiella CC; Ananias RZ; Braga EG; Rodrigues MM; Longo-Maugéri IM
Microbiol Immunol; 2006; 50(4):253-63. PubMed ID: 16625047
[TBL] [Abstract][Full Text] [Related]
32. Efficacy of a trans-sialidase-ISCOMATRIX subunit vaccine candidate to protect against experimental Chagas disease.
Bontempi IA; Vicco MH; Cabrera G; Villar SR; González FB; Roggero EA; Ameloot P; Callewaert N; Pérez AR; Marcipar IS
Vaccine; 2015 Mar; 33(10):1274-83. PubMed ID: 25625671
[TBL] [Abstract][Full Text] [Related]
33. Expression, purification, immunogenicity, and protective efficacy of a recombinant Tc24 antigen as a vaccine against Trypanosoma cruzi infection in mice.
Martinez-Campos V; Martinez-Vega P; Ramirez-Sierra MJ; Rosado-Vallado M; Seid CA; Hudspeth EM; Wei J; Liu Z; Kwityn C; Hammond M; Ortega-López J; Zhan B; Hotez PJ; Bottazzi ME; Dumonteil E
Vaccine; 2015 Aug; 33(36):4505-12. PubMed ID: 26192358
[TBL] [Abstract][Full Text] [Related]
34. Effects of IFN-γ coding plasmid supplementation in the immune response and protection elicited by Trypanosoma cruzi attenuated parasites.
Pérez Brandán C; Mesías AC; Parodi C; Cimino RO; Pérez Brandán C; Diosque P; Basombrío MÁ
BMC Infect Dis; 2017 Nov; 17(1):732. PubMed ID: 29178839
[TBL] [Abstract][Full Text] [Related]
35. Acute Trypanosoma cruzi infection: IL-12, IL-18, TNF, sTNFR and NO in T. rangeli-vaccinated mice.
Basso B; Cervetta L; Moretti E; Carlier Y; Truyens C
Vaccine; 2004 May; 22(15-16):1868-72. PubMed ID: 15121297
[TBL] [Abstract][Full Text] [Related]
36. Plasmid DNA immunization with Trypanosoma cruzi genes induces cardiac and clinical protection against Chagas disease in the canine model.
Rodríguez-Morales O; Pérez-Leyva MM; Ballinas-Verdugo MA; Carrillo-Sánchez SC; Rosales-Encina JL; Alejandre-Aguilar R; Reyes PA; Arce-Fonseca M
Vet Res; 2012 Nov; 43(1):79. PubMed ID: 23148870
[TBL] [Abstract][Full Text] [Related]
37. Experimental Nanovaccine Offers Protection Against Repeat Exposures to
Chowdhury IH; Lokugamage N; Garg NJ
Front Immunol; 2020; 11():595039. PubMed ID: 33414785
[TBL] [Abstract][Full Text] [Related]
38. Novel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.
Silveira EL; Claser C; Haolla FA; Zanella LG; Rodrigues MM
Clin Vaccine Immunol; 2008 Aug; 15(8):1292-300. PubMed ID: 18579696
[TBL] [Abstract][Full Text] [Related]
39. Effect of a combination DNA vaccine for the prevention and therapy of Trypanosoma cruzi infection in mice: role of CD4+ and CD8+ T cells.
Limon-Flores AY; Cervera-Cetina R; Tzec-Arjona JL; Ek-Macias L; Sánchez-Burgos G; Ramirez-Sierra MJ; Cruz-Chan JV; VanWynsberghe NR; Dumonteil E
Vaccine; 2010 Oct; 28(46):7414-9. PubMed ID: 20850536
[TBL] [Abstract][Full Text] [Related]
40. Perforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.
de Alencar BC; Persechini PM; Haolla FA; de Oliveira G; Silverio JC; Lannes-Vieira J; Machado AV; Gazzinelli RT; Bruna-Romero O; Rodrigues MM
Infect Immun; 2009 Oct; 77(10):4383-95. PubMed ID: 19651871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]